FDA QMSR Maintenance Readiness for Device Plants

By James Smith on June 29, 2026

fda-qmsr-maintenance-readiness-for-device-plants

As of February 2, 2026, the FDA's Quality Management System Regulation (QMSR) replaced the 1996-era Quality System Regulation under 21 CFR Part 820 — and the Quality System Inspection Technique (QSIT) was retired the same day, replaced by the updated Compliance Program 7382.850. The new framework incorporates ISO 13485:2016 by reference and applies risk management explicitly across the entire QMS. For medical device manufacturers, the practical impact lands hardest on three operational systems: equipment maintenance evidence, calibration management traceability, and supplier quality records. Industry analyses estimate small-to-mid-size manufacturers face $100K+ in remediation costs when QMS infrastructure was built only to QSR standards. Oxmaint's QMSR-aligned maintenance and calibration platform structures those three systems against the exact evidence FDA investigators are now trained to request under Compliance Program 7382.850 — turning audit week from a four-month preparation crisis into a normal Tuesday.

QMSR Readiness Guide · Medical Device Manufacturing · BOFU

FDA QMSR Maintenance Readiness for Device Plants

QMSR effective February 2, 2026. ISO 13485:2016 incorporated by reference. QSIT retired. Inspection Program 7382.850 now in force. The compliance bar has moved — and equipment maintenance, calibration, and supplier evidence are the three workflows most affected.

02
FEB
2026
RETIRED
21 CFR 820 (QSR)
In force since 1996 · QSIT inspection technique
IN FORCE
21 CFR 820 (QMSR)
ISO 13485:2016 incorporated · Compliance Program 7382.850
FDA Final Rule
Jan 31, 2024
Effective Date
Feb 2, 2026
Incorporates
ISO 13485:2016
Sections Amended
179 across 18 parts
Where Is Your Plant on the QMSR Readiness Curve?
01
Pre-QMSR Posture
QSR-style paper records, maintenance binders, separate calibration spreadsheet, no ISO 13485 alignment

02
Gap Analysis
ISO 13485:2016 audit completed, gaps documented, remediation plan in CAPA system

03
Systems Aligned
Equipment, calibration, supplier records consolidated in QMSR-aligned CMMS with audit trail

Inspection Ready
04
Real-time evidence retrieval, risk-based maintenance documented, no surprises in a 7382.850 inspection

What Changed — QSR vs QMSR at the Maintenance Layer

The QSR and QMSR are "substantially similar" in FDA's own language, but several specific differences land directly on the equipment maintenance and calibration evidence trail. The table below isolates the changes maintenance and quality teams must absorb — not the entire regulatory delta.

Area QSR (Pre-Feb 2026) QMSR (In Force Feb 2026)
Risk-Based Maintenance Implied in QSR preamble · best practice Explicitly required throughout QMS per ISO 13485:2016 + ISO 14971 alignment
Equipment Infrastructure 21 CFR 820.70 · general buildings & equipment requirements ISO 13485 Clause 6.3 Infrastructure · documented maintenance schedules required
Calibration / M&ME Control 21 CFR 820.72 · monitoring & measuring equipment ISO 13485 Clause 7.6 · traceable standards · calibration record retention
Supplier Controls 21 CFR 820.50 · purchasing controls ISO 13485 Clause 7.4 · risk-based supplier evaluation + monitoring documented
Records Retention 21 CFR 820.180 · device-lifetime + 2 years minimum 21 CFR 820.35 · same minimum + ISO 13485 Clause 4.2 record-control requirements
Inspection Method QSIT (Quality System Inspection Technique) Compliance Program 7382.850 · ISO 13485-aligned process
Terminology Management with Executive Responsibility Top Management · Quality Management System (QMS)

The Five Maintenance Pillars QMSR Inspectors Now Look For

A 7382.850 inspection is structured around the ISO 13485 clause framework, not the old QSIT subsystems. Five operational pillars touch directly on equipment maintenance — and each has a specific evidence expectation. ISO 13485 CMMS alignment for medical device compliance maps each pillar to the CMMS capability that produces the required evidence.

01
ISO 13485 Clause 6.3 21 CFR 820

Infrastructure & Equipment Maintenance

Documented maintenance schedules for every piece of production equipment, with records demonstrating execution against schedule. Inspector expectation: per-asset PM frequency justified by manufacturer recommendation, criticality, or historical failure data.

Evidence FDA inspectors request: Asset PM schedule · completion records · technician identification · deviation justifications · CAPA links for missed PM
02
ISO 13485 Clause 7.6 21 CFR 820.72

Monitoring & Measuring Equipment (M&ME) Calibration

All M&ME used to verify product specifications must be calibrated against standards traceable to national or international references (NIST, NPL). Calibration records, status indicators on the equipment, and out-of-tolerance response procedures required.

Evidence FDA inspectors request: Calibration certificates · NIST traceability chain · calibration due dates · OOT (out-of-tolerance) investigations · product impact assessments
03
ISO 13485 Clause 7.4 21 CFR 820.50

Supplier & Outsourced Maintenance Controls

Risk-based supplier evaluation, quality agreements, and ongoing performance monitoring. For outsourced calibration vendors, sterilization providers, and equipment service contractors, the manufacturer remains responsible for the quality of supplied work.

Evidence FDA inspectors request: Supplier qualification records · quality agreements · supplier audit reports · incoming inspection records · supplier performance metrics
04
ISO 13485 Clause 7.5.6 21 CFR 820

Process Validation & Revalidation

Production processes whose output cannot be fully verified by subsequent inspection (sterilization, welding, sealing, certain plastic moulding) must be validated, and revalidated after equipment changes, repairs above a defined threshold, or major maintenance events.

Evidence FDA inspectors request: Validation protocols (IQ/OQ/PQ) · revalidation triggers · post-repair revalidation records · risk-based revalidation justification
05
ISO 13485 Clause 8.5 21 CFR 820.100

CAPA Integration With Maintenance Events

Maintenance events that indicate a systemic problem — recurring failures, OOT calibrations, supplier defects — must feed the Corrective and Preventive Action (CAPA) system. Inspectors increasingly trace from CAPA records back into maintenance history to validate the linkage.

Evidence FDA inspectors request: Trend analysis on maintenance failures · CAPA records linked to equipment · effectiveness verification · risk-based CAPA prioritisation

The FDA Inspector Readiness Checklist — 7382.850 Alignment

A 7382.850 inspection follows a structured path through the QMS. This checklist captures the eight evidence requests most consistently raised in the first wave of QMSR-era inspections. CMMS-driven FDA inspection readiness is built around producing each of these in under 60 seconds during a live inspection.

Equipment & Maintenance Records
Audit-Ready
Show me the maintenance schedule and last 12 months of completed PMs for [specific equipment ID]
CMMS asset view filtered by date · printable evidence pack export · technician sign-offs visible
Audit-Ready
How do you justify the PM frequency on this asset?
Asset record with criticality classification · OEM-recommended interval reference · historical failure data trend
Common Gap
What was the corrective action for this missed PM in the cleanroom mould press?
Missed PM → CAPA link · investigation record · effectiveness verification · approval signatures
Calibration & M&ME
Audit-Ready
Show me the calibration history and NIST traceability chain for this torque tool
Calibration certificate · standards traceability · due-date reminders · technician credentials
Critical Gap
This gauge calibrated as out-of-tolerance in March — what product was affected and what was the disposition?
OOT investigation record · product impact assessment · lot containment · CAPA linkage · customer notifications if applicable
Supplier & Outsourced Services
Common Gap
What is your qualification record for the contractor servicing your sterilization equipment?
Supplier qualification file · quality agreement · audit history · ongoing performance review · risk-based re-evaluation schedule
Audit-Ready
Show me the certification of work performed by your calibration laboratory on this M&ME
Vendor calibration certificate · attached to asset record · linked to PO and contract · accessible by asset search
CAPA & Validation
Common Gap
When the sealing machine had its motor replaced in August, what revalidation was performed?
Equipment change record · revalidation trigger logic · IQ/OQ/PQ documentation · Top Management approval

The Documentation Evidence Matrix — Records Required by Activity Type

Every maintenance activity touching production equipment generates a different set of required records under QMSR. The matrix below maps the activity type to the records the CMMS must capture to satisfy the ISO 13485 clauses incorporated by reference.

Maintenance Activity PM Record Calibration Cert Tech Credentials Revalidation CAPA Link Supplier File
Scheduled PM (in-house) Required Required If triggered If pattern
Corrective Repair Required If applicable Required Per protocol Required
Calibration of M&ME Required Required Required If OOT If outsourced
Outsourced Calibration Required Required If OOT Required
Equipment Modification Required If applicable Required Required Per protocol
Vendor-Performed Service Required If applicable Per protocol If pattern Required
Required record — produced for every event
Conditional — required when trigger met
Not applicable to this activity type

A QMSR Inspection Is a Test of Your Evidence Retrieval Speed — Not Your Equipment.

OxMaint structures every maintenance event, calibration cycle, and supplier interaction into a single audit-grade record system aligned to ISO 13485:2016 clauses and Compliance Program 7382.850 inspection paths.

The Calibration Workflow Under ISO 13485 Clause 7.6

Of all maintenance activities under QMSR, calibration of monitoring & measuring equipment has the highest evidence density per cycle. Calibration management for 21 CFR 820 CMMS means the workflow itself must be designed to satisfy ISO 13485 Clause 7.6 — not retrofitted afterwards.

01
Asset Registration
M&ME entered with serial number, manufacturer, accuracy class, calibration interval, criticality
ISO 13485 7.6(a)

02
Calibration Schedule
Auto-generated based on interval; status indicator on physical equipment; due-date dashboard
ISO 13485 7.6(c)

03
Calibration Execution
In-house or outsourced; traceable standards documented; pre-/post-cal readings captured
ISO 13485 7.6(a)(b)

04
Record & Certificate
Certificate attached to asset; tech ID logged; NIST traceability chain documented
ISO 13485 7.6(e)

05
OOT Response
If out-of-tolerance: product impact assessment, lot containment, CAPA, customer action if needed
ISO 13485 7.6(d)

The Supplier Evidence Chain — Risk-Based Per Clause 7.4

QMSR's risk-based framing changes the supplier evidence expectation. It is no longer sufficient to have a signed quality agreement on file — the manufacturer must demonstrate active, ongoing supplier evaluation proportional to the risk that supplier introduces into the device. Medical device supplier quality records management is the workflow that produces this chain continuously, not at audit time.

A
High-Risk Suppliers
Sterilization · critical raw materials · contract sterilizers · OEM service contractors on production equipment
Required Evidence: Annual on-site audits · full quality agreement · CAPA flow-through · escape rate monitoring · supplier change notifications
B
Medium-Risk Suppliers
Calibration labs · validated components · cleanroom service vendors · process consumables
Required Evidence: Biennial document review · incoming inspection records · quality agreement · performance metrics review · ISO 17025 certificates (for cal labs)
C
Low-Risk Suppliers
Office supplies · indirect maintenance items · non-product-contact consumables · standard hand tools
Required Evidence: Approved vendor list · purchase order history · simple acceptance documentation · escalation path for quality complaints

The Cost of QMSR Non-Compliance — Why CMMS Investment Pays Back in One Inspection

QMSR compliance investment is best framed against the cost of FDA enforcement action, not against productivity savings alone. The escalation ladder is well-documented: Form 483 → Warning Letter → Consent Decree → Product Seizure. Each step compounds the financial and reputational impact significantly.

Scenario: Mid-Size Medical Device Manufacturer · ~$80M Revenue · Two Production Sites
Single Form 483 with multiple observations · remediation cost
$150K–$500K
FDA Warning Letter response & remediation
$500K–$2M
Consent Decree (multi-year monitor + plant restrictions)
$5M–$30M+
Product Seizure / Import Alert · revenue impact
$2M–$50M+
Small firm QMSR remediation cost (Apex industry estimate)
~$100K minimum
OxMaint platform + onboarding (annual)
$30K–$80K
Audit-week preparation time reduction ~75% lower
Evidence retrieval during live inspection < 60 seconds per request
Payback on single avoided 483 observation Multiple years of platform cost

QMSR-Specific KPIs Maintenance & Quality Teams Now Track

Pre-QMSR, equipment maintenance KPIs focused mostly on operational metrics — wrench time, MTBF, schedule compliance. Under QMSR, the metrics expand to include explicit quality and compliance dimensions. These are the six the maintenance director and quality manager now jointly review.

Target: 100%

PM Schedule Compliance

Percentage of preventive maintenance completed within its defined window. Below 100% requires documented deviation justification with risk assessment under ISO 13485 Clause 6.3. Inspectors trace missing PM directly.

Target: 100%

Calibration On-Time Rate

Percentage of M&ME calibrations completed before due date. A single overdue calibration on production-impact equipment is a typical Form 483 observation under Compliance Program 7382.850.

Target: < 60 sec

Evidence Retrieval Time

Time from FDA investigator request to producing the requested record. Above two minutes during live inspection erodes inspector confidence and increases the depth of subsequent requests.

Target: 100%

OOT Closure Rate

Percentage of out-of-tolerance calibration findings closed with documented product impact assessment, lot containment decision, and CAPA linkage. Open OOTs are the highest-leverage finding in any QMSR inspection.

Target: > 95%

Supplier Audit Currency

Percentage of high-risk suppliers with current quality audit per the risk-based audit schedule under Clause 7.4. Skipped audits on critical suppliers (sterilizers, cal labs) are repeat findings in early QMSR-era inspections.

Target: 100%

Maintenance-CAPA Linkage

Percentage of recurring maintenance failures (3+ events on same equipment) escalated into CAPA. The connection inspectors now trace under Clause 8.5 — failure trends without CAPA evidence is a near-automatic finding.

Expert Review — A Medical Device Quality Director's Perspective

"

I have prepared three medical device sites for FDA inspections under the old QSIT framework and one under the new Compliance Program 7382.850. The difference in inspector behaviour is immediate and significant. Under QSIT, the investigator worked through the seven QSR subsystems on a relatively predictable path. Under 7382.850, the investigator follows the ISO 13485 risk-based logic — they pick a high-risk asset, trace its entire maintenance and calibration history, follow the supplier chain backwards, and then jump into CAPA to verify the linkage to systemic issues. There is no warning, no QSIT-style structure, and no time to assemble evidence after the request. If your CMMS cannot produce a complete equipment dossier in under sixty seconds — with PM history, calibration certificates, technician credentials, supplier records, and any linked CAPA all in one view — you will receive a Form 483. The investment in a properly structured maintenance and calibration system is not a productivity decision under QMSR. It is a regulatory survival decision. The plants that understood this in 2025 and built their evidence infrastructure ahead of February 2026 are now passing inspections that catch unprepared peers off-guard.

Dr. Anjali Brennan-Park, RAC, CQA
Director of Quality & Regulatory Affairs — Mid-Atlantic Medical Device Manufacturer · 18 Years in FDA-Regulated Quality Systems · RAC-Certified (Regulatory Affairs Certification, US) · ASQ Certified Quality Auditor · Specialism in QSR-to-QMSR Transition Programs and Compliance Program 7382.850 Inspection Readiness

Frequently Asked Questions

Does QMSR replace 21 CFR Part 820 entirely, or does Part 820 still exist?

21 CFR Part 820 still exists — but the content is now substantially the QMSR, which incorporates ISO 13485:2016 by reference. The title of Part 820 changed from "Quality System Regulation" to "Quality Management System Regulation" on February 2, 2026. The structure still lives at the same CFR citation, but the substantive requirements now point to ISO 13485 with FDA-specific additions in 21 CFR 820.10 (covering UDI, MDR, corrections and removals, record control, and labeling). 179 sections across 18 parts of Title 21 were updated to align with the new framework. Book a demo to walk through how OxMaint maps to each clause.

Does ISO 13485:2016 certification exempt a manufacturer from FDA inspection under QMSR?

No. The FDA has explicitly stated that ISO 13485 certification will not exempt a manufacturer from FDA inspection under QMSR. The FDA does not issue and does not recognize third-party ISO 13485 certificates of conformance as a substitute for inspection. FDA inspections under Compliance Program 7382.850 assess compliance with the QMSR — which includes both the incorporated ISO 13485 requirements and the FDA-specific provisions in 21 CFR 820.10. Manufacturers participating in MDSAP (Medical Device Single Audit Program) still face FDA inspections separately. Start free in OxMaint to build the evidence base for both inspection types.

What is the practical difference between the QSIT inspection technique and Compliance Program 7382.850?

QSIT was a top-down, subsystem-by-subsystem inspection technique structured around the seven QSR major subsystems (Management Controls, Design Controls, CAPA, Production & Process Controls, etc.). It was relatively predictable. Compliance Program 7382.850 follows the ISO 13485 risk-based logic instead: investigators select high-risk products, processes, or equipment and trace the QMS evidence outward from that anchor point. The inspection feels less structured and more probing, jumping between maintenance, calibration, supplier, and CAPA records based on what the investigator finds at each step. CAPA workflows for medical device CMMS become particularly important under this approach. Book a demo to see how OxMaint structures evidence for the new inspection model.

Our maintenance records are still on paper and in spreadsheets. What is the realistic timeline to become QMSR-ready?

For a mid-size manufacturer transitioning from paper records and spreadsheets, the typical timeline is 4–6 months to full QMSR maintenance readiness: Months 1–2 cover asset registry build, criticality classification, and ISO 13485 gap analysis. Months 3–4 cover digital PM schedules, calibration intervals, and supplier file consolidation in the CMMS. Months 5–6 cover live operations, mock inspections, and CAPA integration. The hardest single component is supplier file consolidation — most manufacturers have supplier records distributed across QA, Purchasing, Engineering, and Maintenance with no single source of truth. Sign in to OxMaint to start the asset registry phase today.

How does OxMaint handle the electronic records requirements that apply to QMSR-compliant maintenance systems?

OxMaint's audit trail captures the elements the FDA expects in electronic records: user identification, timestamped actions, before-and-after values on changes, electronic signatures, access controls, and tamper-evident logs. For medical device manufacturers, this aligns with the record-control requirements in 21 CFR 820.35 and the corresponding ISO 13485 Clause 4.2 provisions. The electronic record can be exported as an audit-grade evidence package on request — typically the format FDA investigators ask for once they have validated the underlying records on-screen. Book a demo to walk through the audit trail export workflow.

February 2, 2026 Was Yesterday. The Next Inspection Could Be Tomorrow.

OxMaint builds the maintenance, calibration, and supplier evidence infrastructure your QMS now requires under QMSR — aligned to ISO 13485:2016 clauses, ready for Compliance Program 7382.850 inspection paths, and producing audit-grade evidence on every transaction.